Home page > Europe and Health | Health, wealth and equity | Health friendly research and innovation | EU Funding and programmes | Irish Presidency priorities


Please find all related articles below.

Exploring the future of ’Science Shops’

The European Commission hosted a conference to review the successes of a network of Science Shops and explored opportunities to enlarge the network of partners. The EPHA Secretariat attended the meeting organised by the DG Research together with representatives from NGO’s, Universities and existing Science Shops from throughout Europe. Science shops are organisations created as mediators between citizen groups (trade unions, pressure groups, non-profit organisations, social groups, (...)
Also about: Civil Society

Regional view on health from Finland

A number of European regional representatives, EU officials and met in Brussels to discuss how regional authorities could address health issues. Key health determinants were addressed at the conference which highlighted the results of the "Health Kuopio" project: healthy ageing, food and nutrition, pharmaceuticals, environment and e-Health. The Finnish region of Kuopio is developing a science park in cooperation with the University of Kuopio and the private sector. This partnership is (...)

Consultation on the 7th Research Framework

The European Commission is undertaking a consultation to identify ’thematic domains’ for future European support under the 7th Framework Programme. The European Commission is using the following three criteria in order to identify which thematic domains will be included in the proposal for the 7th Framework Programme. Contribution to EU policy objectives The research topic must generate new knowledge to meet societal needs and catalyse the delivery of a European policy (...)

Malaria vaccine developments

An new vaccine in development has shown positive results in paediatric trials against the malaria that is found in the developing world (RTS,S/ASO2A). The study, published in the "The Lancet", shows the results of a vaccine, developed by GlaxoSmithkline (GSK) Biologics and tested amongst children between one and four years old for a period of six months in Mozambique. This vaccine was first tested in adults in Belgium, Kenya, The Gambia, and the US. It has since been tested in children in (...)

Commission consultation on nanotechnology

The Commission is launching a wide consultation on its Communication Towards a European Strategy for Nanotechnology in which it proposed an integrated and responsible approach for developing nanosciences and nanotechnologies in Europe. Nanotechnology is a new approach to research and development for controlling the fundamental structure and behaviour of matter at the level of atoms and molecules. Applications are emerging in many different areas such as health care, information (...)

EU funds research project on drug resistance

The EU announced on the 28th June 2004 a contribution of €9 million to the “Vigilance against Viral Resistance” (VIRGIL) project. This project intends to start by studying viral hepatitis and influenza, and then broadening to other viruses. The network will be based on research and technological platforms to monitor existing, and anticipate future, drug resistance. The VIRGIL project is coordinated by Lyon’s INSERM research centre and gathers 55 key European field (...)

EU industry ministers call for less red tape and regulation

On 17 May 2004, the EU Competitiveness Council approved a timetable to identify priority areas for lighter European regulation on industry and business "with a view to agreement before the end of 2004". The Council has also asked the European Commission to develop a method to assess administrative burdens on industry and report to the Ministers in November. The trade and industry Ministers called for reduced regulation, new policies to stimulate private investment in scientific research, (...)

Report on the link between science and public health policy

The Wellcome Trust has published a report on the state of public health sciences in the UK and made recommendations on measures to enhance the impact upon the public health. A working group was convened to address public health sciences and how they relate to public health practice in the inter-related areas of health services, health protection and health improvement. The report notes that impressive achievements in the biomedical sciences and medical care can obscure the fact that the (...)

Effects of mercury contamination of seafood in children’s health

Scientists at the Harvard School of Public Health announced on 3 February that methyl mercury contamination of seafood can cause heart and brain damage in children. The study, published in the February 2004 issue of the Journal of Pediatrics, found that brain signals controlling heart rates were significantly slower in children whose mothers had the most mercury in their systems during their (...)

EMBO launches new life sciences mobility portal

The European Molecular Biology Organisation (EMBO) has launched a new online life sciences mobility consultancy (LSMC), with help from the European Commission’s research Framework Programme. The website includes searchable information on grants, fellowships, awards, workshops and practical courses in the life sciences, as well as listings of scientific vacancies throughout (...)
Also about: